Economic impact of anti-IL-5 agents in patients with severe eosinophilic asthma: A population-based cohort study-Reference-Cited by-同舟云学术

Economic impact of anti-IL-5 agents in patients with severe eosinophilic asthma: A population-based cohort study

Published:2022-11 Issue:11 Volume:10 Page:3026-3028.e2
ISSN:2213-2198
Container-title:The Journal of Allergy and Clinical Immunology: In Practice
language:en
Short-container-title:The Journal of Allergy and Clinical Immunology: In Practice

Author:

Faverio Paola^ORCID,Monzio Compagnoni Matteo,Ronco Raffaella,Franchi Matteo,Della Zoppa Matteo,Bonaiti Giulia,Bonifazi Martina,Mei Federico,Luppi Fabrizio,Pesci Alberto,Corrao Giovanni

Funder

Agenzia Italiana del Farmaco, Ministero della Salute

Ministero dell’Istruzione, dell’Università e della Ricerca

European Commission

Publisher

Elsevier BV

Subject

Immunology and Allergy

Reference9 articles.

1. Efficacy and safety of anti-interleukin-5 therapy in patients with asthma: a systematic review and meta-analysis;Wang;PLoS One,2016

2. The path to personalized medicine in asthma;Bagnasco;Expert Rev Respir Med,2016

3. Adherence to corticosteroids and clinical outcomes in mepolizumab therapy for severe asthma;D’Ancona;Eur Respir J,2020

4. Adherence to inhaled corticosteroids and clinical outcomes following a year of benralizumab therapy for severe eosinophilic asthma;D’Ancona;Allergy,2021

5. Discontinuation of benralizumab in Canadian patients with severe eosinophilic asthma;Noorduyn;ERJ Open Res,2021

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Healthcare costs and resources utilization in children with difficult‐to‐control asthma treated with biologic therapies: A population‐based cohort study;Pediatric Pulmonology;2023-11-22